<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>insulin Archives - BCDiabetes</title>
	<atom:link href="https://www.bcdiabetes.ca/tag/insulin/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>British Columbia Diabetes Care, Research, and Education</description>
	<lastBuildDate>Tue, 28 May 2019 18:26:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.bcdiabetes.ca/wp-content/uploads/2018/04/favicon-150x150.png</url>
	<title>insulin Archives - BCDiabetes</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>BC Pharmacare to cover SGLT-2 inhibitors and to delist the Lantus brand of insulin glargine U100</title>
		<link>https://www.bcdiabetes.ca/bc-pharmacare-sglt-2-inhibitors-and-lantus-brand-of-insulin/</link>
		
		<dc:creator><![CDATA[Dr. Tom Elliott]]></dc:creator>
		<pubDate>Tue, 28 May 2019 17:30:22 +0000</pubDate>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Living With Diabetes]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[living with diabetes]]></category>
		<category><![CDATA[medications]]></category>
		<category><![CDATA[sglt2]]></category>
		<guid isPermaLink="false">https://www.bcdiabetes.ca/?p=2572</guid>

					<description><![CDATA[<p>Yesterday BC Minister of Health Adrian Dix announced Pharmacare coverage of the SGLT-2 inhibitor class represented by empagliflozin (Jardiance). Although BCDiabetes would have preferred that all three SGLT2 inhibitors on the Canadian market be covered, the long overdue announcement was most welcome news. Our readers will be aware of the long-running BCDiabetes advocacy campaign for [&#8230;]</p>
<p>The post <a href="https://www.bcdiabetes.ca/bc-pharmacare-sglt-2-inhibitors-and-lantus-brand-of-insulin/" data-wpel-link="internal">BC Pharmacare to cover SGLT-2 inhibitors and to delist the Lantus brand of insulin glargine U100</a> appeared first on <a href="https://www.bcdiabetes.ca" data-wpel-link="internal">BCDiabetes</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>95 Years of Insulin &#038; Embracing the Tech Era</title>
		<link>https://www.bcdiabetes.ca/95-years-of-insulin-embracing-the-tech-era/</link>
		
		<dc:creator><![CDATA[Dr. Tom Elliott]]></dc:creator>
		<pubDate>Wed, 03 May 2017 20:27:16 +0000</pubDate>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Living With Diabetes]]></category>
		<category><![CDATA[News & Media]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[mybcd]]></category>
		<guid isPermaLink="false">https://www.bcdiabetes.ca/?p=1607</guid>

					<description><![CDATA[<p>Today marks the 95th anniversary of the first use of the word insulin by its Canadian discovers Dr. Frederick Banting and medical student Charles Best.  Four months earlier they had saved the life of 14 year old Leonard Thompson by injecting him with a pancreatic extract (containing insulin) taken from a dog.  A year later Banting [&#8230;]</p>
<p>The post <a href="https://www.bcdiabetes.ca/95-years-of-insulin-embracing-the-tech-era/" data-wpel-link="internal">95 Years of Insulin &#038; Embracing the Tech Era</a> appeared first on <a href="https://www.bcdiabetes.ca" data-wpel-link="internal">BCDiabetes</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>There is no insulin pill&#8230;. yet.</title>
		<link>https://www.bcdiabetes.ca/there-is-no-insulin-pill-yet/</link>
		
		<dc:creator><![CDATA[Dave]]></dc:creator>
		<pubDate>Wed, 23 Nov 2016 22:11:07 +0000</pubDate>
				<category><![CDATA[Living With Diabetes]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Diabetes Research]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[Type 1 Diabetes]]></category>
		<category><![CDATA[Type 2 Diabetes]]></category>
		<guid isPermaLink="false">https://www.bcdiabetes.ca/?p=1407</guid>

					<description><![CDATA[<p>The search for a pill formulation of insulin has been long-standing.  Yesterday Novo Nordisk, the world&#8217;s biggest insulin manufacturer abandoned its efforts to make an oral form of insulin.  The obstacle was not technological it was price pressure. The pharmaceutical industry has figured out how to protect insulin from digestive juices in the stomach &#8211; [&#8230;]</p>
<p>The post <a href="https://www.bcdiabetes.ca/there-is-no-insulin-pill-yet/" data-wpel-link="internal">There is no insulin pill&#8230;. yet.</a> appeared first on <a href="https://www.bcdiabetes.ca" data-wpel-link="internal">BCDiabetes</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
